About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05668104

Jing Si Herbal Tea for Long-Coronavirus Disease(COVID) Gut-brain Interaction

Dyspepsia refers to chronic or recurrent upper gastrointestinal symptoms. According to the Rome IV criteria, functional dyspepsia (FD) symptoms included meal related fullness, early satiation, epigast...

Lead sponsor: Buddhist Tzu Chi General Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Buddhist Tzu Chi General Hospital

Age

20 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Age between 20-70 years old.
•2. Those who meet the definition of functional dyspepsia (FD). (Functional dyspepsia (FD) is chronic (once a week, lasting at least three months, at least six months before the first symptom) upper gastrointestinal symptoms (any of the following): postprandial abdominal distension, easy to feel full, Epigastric pain or burning sensation in the upper abdomen, and no symptoms of gastrointestinal bleeding or significant weight loss, no abnormality after upper gastrointestinal endoscopy).
•3. Those who meet the definition of irritable bowel syndrome (IBS). (Irritable bowel syndrome (IBS) is chronic (once a week, lasting for at least three months) lower gastrointestinal symptoms: abdominal pain combined with diarrhea or constipation, and no symptoms of gastrointestinal bleeding or significant weight loss, no abnormalities after colonoscopy) .
•4. Be conscious and willing to sign the subject's consent form.

Exclusion Criteria

•1. Abnormal liver and kidney function;
•2. Abnormal blood tests and thyroid abnormalities;
•3. Have received surgery on the digestive tract;
•4. Abnormal upper gastrointestinal endoscopy;
•5. Abnormal colonoscopy;
•6. Antibiotics are being used for infectious diseases;
•7. Pregnant or breastfeeding women;
•8. Suffering from heart, liver, or kidney failure;
•9. Physical weakness, allergies, asthenia and cold constitution and chronic diseases.

Related studies

RECRUITINGPhase 1/2

Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome

NCT07481422 · Irritable Bowel Syndrome (IBS)

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713 · Healthy Participants, Healthy Subjects, and more

RECRUITINGEARLY Phase 1

Single-tracer Multiparametric PET Imaging

NCT06014515 · Healthy Subjects, Cardiovascular Disease

Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

NCT05740319 · Irritable Bowel Syndrome

Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children

NCT05730491 · Irritable Bowel Syndrome, Abdominal Pain

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment32

Start dateJan 2023

Last updatedJan 9, 2024

Condition

Healthy Subjects COVID-19 Pneumonia Irritable Bowel Syndrome Functional Gastrointestinal Disorders

Locations shown

Hualien Tzu Chi Hospital

Hualien City

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions